AZN Latest Headlines

SA Asks: What's the outlook for Big Pharma M&A?

at seekingalpha.com (Sat, 8-Aug 3:28 PM)

Trending stocks this week as SpaceX, Palantir earnings and jobs data drive markets

at seekingalpha.com (Sat, 8-Aug 1:12 PM)

Roche upgraded at Morgan Stanley on growth, pipeline upside

at seekingalpha.com (Fri, 7-Aug 11:30 AM)

AstraZeneca: Buy Rating Reiterated on Attractive Valuation, Robust Pipeline, and Unchanged $16,500 Price Target

at www.tipranks.com (Fri, 7-Aug 6:15 AM)

Jefferies Reaffirms Their Buy Rating on AstraZeneca (AZN)

at www.tipranks.com (Fri, 7-Aug 2:05 AM)

No $400B Mega Merger? AstraZeneca Rises, Bristol Myers Falls as Report Denies Deal

at www.tipranks.com (Wed, 5-Aug 10:48 AM)

Bristol-Myers falls on report there are no talks going on with AstraZeneca

at seekingalpha.com (Wed, 5-Aug 8:16 AM)

Bristol-Myers Squibb, AstraZeneca deal talks remain active - report

at seekingalpha.com (Tue, 4-Aug 1:03 PM)

AstraZeneca (AZN) Gets a Sell from Deutsche Bank

at www.tipranks.com (Tue, 4-Aug 9:15 AM)

AstraZeneca (AZN) Receives a Buy from UBS

at www.tipranks.com (Tue, 4-Aug 4:57 AM)

AstraZeneca Delivers 6% H1 Revenue Growth and Expands Pipeline with Major Regulatory Wins

Market Chameleon (Mon, 27-Jul 7:09 AM)

AstraZeneca and Abbisko Partner on First-in-Class Oral PD-L1 Therapy to Address Unmet Needs in EGFR-Mutated NSCLC

Market Chameleon (Thu, 2-Jul 7:29 AM)

FDA Approval of BAXFENDY Sets New Benchmark in Hypertension Treatment—AstraZeneca’s Latest Win Offers Hope for 23 Million US Patients

Market Chameleon (Mon, 18-May 9:21 AM)